Literature DB >> 17442929

Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference.

Mu Li1, Xusheng Zhang, Xiufen Zheng, Dameng Lian, Zhu-Xu Zhang, Weiwen Ge, Jinming Yang, Costin Vladau, Motohiko Suzuki, Dong Chen, Robert Zhong, Bertha Garcia, Anthony M Jevnikar, Wei-Ping Min.   

Abstract

Dendritic cells (DC), the most potent APCs, can initiate the immune response or help induce immune tolerance, depending upon their level of maturation. DC maturation is associated with activation of the NF-kappaB pathway, and the primary NF-kappaB protein involved in DC maturation is RelB, which coordinates RelA/p50-mediated DC differentiation. In this study, we show that silencing RelB using small interfering RNA results in arrest of DC maturation with reduced expression of the MHC class II, CD80, and CD86. Functionally, RelB-silenced DC inhibited MLR, and inhibitory effects on alloreactive immune responses were in an Ag-specific fashion. RelB-silenced DC also displayed strong in vivo immune regulation. An inhibited Ag-specific response was seen after immunization with keyhole limpet hemocyanin-pulsed and RelB-silenced DC, due to the expansion of T regulatory cells. Administration of donor-derived RelB-silenced DC significantly prevented allograft rejection in murine heart transplantation. This study demonstrates for the first time that transplant tolerance can be induced by means of RNA interference using in vitro-generated tolerogenic DC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442929     DOI: 10.4049/jimmunol.178.9.5480

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.

Authors:  D Rojas-Canales; R Krishnan; C F Jessup; P T Coates
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 2.  Advancements in immune tolerance.

Authors:  Ping-Ying Pan; Junko Ozao; Zuping Zhou; Shu-Hsia Chen
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

3.  Probiotic metabolites from Bacillus coagulans GanedenBC30™ support maturation of antigen-presenting cells in vitro.

Authors:  Kathleen F Benson; Kimberlee A Redman; Steve G Carter; David Keller; Sean Farmer; John R Endres; Gitte S Jensen
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

Review 4.  Tolerogenic dendritic cells and their applications in transplantation.

Authors:  Haibin Li; Bingyi Shi
Journal:  Cell Mol Immunol       Date:  2014-08-11       Impact factor: 11.530

5.  Tolerogenic Dendritic Cells Attenuate Experimental Autoimmune Antimyeloperoxidase Glomerulonephritis.

Authors:  Dragana Odobasic; Virginie Oudin; Kenji Ito; Poh-Yi Gan; A Richard Kitching; Stephen R Holdsworth
Journal:  J Am Soc Nephrol       Date:  2019-08-23       Impact factor: 10.121

6.  PD-L1- and calcitriol-dependent liposomal antigen-specific regulation of systemic inflammatory autoimmune disease.

Authors:  Ryan Galea; Hendrik J Nel; Meghna Talekar; Xiao Liu; Joshua D Ooi; Megan Huynh; Sara Hadjigol; Kate J Robson; Yi Tian Ting; Suzanne Cole; Karyn Cochlin; Shannon Hitchcock; Bijun Zeng; Suman Yekollu; Martine Boks; Natalie Goh; Helen Roberts; Jamie Rossjohn; Hugh H Reid; Ben J Boyd; Ravi Malaviya; David J Shealy; Daniel G Baker; Loui Madakamutil; A Richard Kitching; Brendan J O'Sullivan; Ranjeny Thomas
Journal:  JCI Insight       Date:  2019-09-19

7.  Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.

Authors:  Huan Yang; Yong Zhang; Minghua Wu; Jing Li; Wenbin Zhou; Guiyuan Li; Xiaoling Li; Bo Xiao; Premkumar Christadoss
Journal:  Inflamm Res       Date:  2009-09-19       Impact factor: 4.575

8.  LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.

Authors:  Amy E Anderson; David J Swan; Bethan L Sayers; Rachel A Harry; Angela M Patterson; Alexei von Delwig; John H Robinson; John D Isaacs; Catharien M U Hilkens
Journal:  J Leukoc Biol       Date:  2008-11-06       Impact factor: 4.962

Review 9.  Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer.

Authors:  Sander W Tas; Margriet J B M Vervoordeldonk; Paul P Tak
Journal:  Curr Gene Ther       Date:  2009-06       Impact factor: 4.391

10.  RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis.

Authors:  Xiufen Zheng; Motohiko Suzuki; Xusheng Zhang; Thomas E Ichim; Fei Zhu; Hong Ling; Aminah Shunnar; Michael H Wang; Bertha Garcia; Robert D Inman; Wei-Ping Min
Journal:  Arthritis Res Ther       Date:  2010-01-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.